4//SEC Filing
Silverman Joshua 4
Accession 0001683168-26-000148
CIK 0001157075other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:43 PM ET
Size
15.7 KB
Accession
0001683168-26-000148
Insider Transaction Report
Form 4
Silverman Joshua
DirectorCEO and President
Transactions
- Purchase
Common Stock
2026-01-05$0.78/sh+30,000$23,493→ 346,250 total - Purchase
Common Stock
2026-01-06$0.79/sh+30,000$23,667→ 376,250 total - Purchase
Common Stock
2026-01-07$0.83/sh+40,000$33,316→ 416,250 total
Holdings
- 50,000(indirect: By LLC)
Common Stock
Documents
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Entity typeother
Related Parties
1- filerCIK 0001524858
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:43 PM ET
- Size
- 15.7 KB